{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,25]],"date-time":"2026-10-25T00:36:07Z","timestamp":1792888567203,"version":"4.5.0"},"reference-count":36,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,8,1]],"date-time":"2026-08-01T00:00:00Z","timestamp":1785542400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,8,1]],"date-time":"2026-08-01T00:00:00Z","timestamp":1785542400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,4,29]],"date-time":"2026-04-29T00:00:00Z","timestamp":1777420800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100000781","name":"European Research Council","doi-asserted-by":"publisher","award":["834370"],"award-info":[{"award-number":["834370"]}],"id":[{"id":"10.13039\/501100000781","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100002322","name":"Coordination for the improvement of Higher Education Personnel","doi-asserted-by":"publisher","award":["88881.171440\/2018-01"],"award-info":[{"award-number":["88881.171440\/2018-01"]}],"id":[{"id":"10.13039\/501100002322","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001602","name":"Taighde \u00c9ireann \u2013 Research Ireland","doi-asserted-by":"publisher","award":["22\/FFP-A\/1059"],"award-info":[{"award-number":["22\/FFP-A\/1059"]}],"id":[{"id":"10.13039\/501100001602","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001602","name":"Taighde \u00c9ireann \u2013 Research Ireland","doi-asserted-by":"publisher","award":["20\/SPP\/3685"],"award-info":[{"award-number":["20\/SPP\/3685"]}],"id":[{"id":"10.13039\/501100001602","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100010665","name":"H2020 Marie Sk\u0142odowska-Curie Actions","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100010665","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100006366","name":"Minist\u00e9rio da Educa\u00e7\u00e3o","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100006366","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100010661","name":"Horizon 2020 Framework Programme","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100010661","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100018693","name":"Horizon 2020","doi-asserted-by":"publisher","award":["813343"],"award-info":[{"award-number":["813343"]}],"id":[{"id":"10.13039\/100018693","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Biochemical Pharmacology"],"published-print":{"date-parts":[[2026,8]]},"DOI":"10.1016\/j.bcp.2026.118007","type":"journal-article","created":{"date-parts":[[2026,4,25]],"date-time":"2026-04-25T15:36:18Z","timestamp":1777131378000},"page":"118007","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"special_numbering":"P2","title":["4-Octyl itaconate blocks STAT3-induced ACE2 expression to reduce uptake of SARS-CoV-2"],"prefix":"10.1016","volume":"250","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-8265-8644","authenticated-orcid":false,"given":"Hauke J.","family":"Weiss","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alexander","family":"Hooftman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Clarisse","family":"Salgado-Benvindo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Robbert","family":"Boudewijns","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Laurens","family":"Liesenborghs","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tristram A.J.","family":"Ryan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Demi","family":"van der Horst","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Madalina E.","family":"Carter-Timofte","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hossam","family":"Gewaid","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andrew G.","family":"Bowie","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hendrik Jan","family":"Thibaut","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kai","family":"Dallmeier","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David","family":"Olagnier","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Martijn J.","family":"van Hemert","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Luke A.J.","family":"O\u2019Neill","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.bcp.2026.118007_b0005","doi-asserted-by":"crossref","unstructured":"M.C. Grant, L. Geoghegan, M. Arbyn, Z. Mohammed, L. McGuinness, E.L. Clarke, et al., The prevalence of symptoms in 24,410 adults infected by the novel coronavirus (SARS-CoV-2; COVID-19): A systematic review and meta-analysis of 148 studies from 9 countries. Hirst JA, editor. PLoS One. 2020 Jun 23;15(6):e0234765.","DOI":"10.1371\/journal.pone.0234765"},{"issue":"7","key":"10.1016\/j.bcp.2026.118007_b0010","doi-asserted-by":"crossref","first-page":"1017","DOI":"10.1038\/s41591-020-0968-3","article-title":"Extrapulmonary manifestations of COVID-19","volume":"26","author":"Gupta","year":"2020","journal-title":"Nat. Med."},{"issue":"7798","key":"10.1016\/j.bcp.2026.118007_b0015","doi-asserted-by":"crossref","first-page":"270","DOI":"10.1038\/s41586-020-2012-7","article-title":"A pneumonia outbreak associated with a new coronavirus of probable bat origin","volume":"579","author":"Zhou","year":"2020","journal-title":"Nature"},{"issue":"2","key":"10.1016\/j.bcp.2026.118007_b0020","doi-asserted-by":"crossref","first-page":"365","DOI":"10.1161\/HYPERTENSIONAHA.115.06892","article-title":"Angiotensin-converting enzyme 2 metabolizes and partially inactivates pyr-apelin-13 and apelin-17","volume":"68","author":"Wang","year":"2016","journal-title":"Hypertension"},{"key":"10.1016\/j.bcp.2026.118007_b0025","doi-asserted-by":"crossref","unstructured":"N. Vadgama, A. Kreymerman, J. Campbell, O. Shamardina, C. Brugger, G.E. Research Consortium, et al., SARS-CoV-2 Susceptibility and ACE2 Gene Variations Within Diverse Ethnic Backgrounds, Front Genet. 2022 Apr 27;13.","DOI":"10.3389\/fgene.2022.888025"},{"issue":"1","key":"10.1016\/j.bcp.2026.118007_b0030","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1186\/s40246-020-00279-z","article-title":"Analysis of ACE2 genetic variants in 131 Italian SARS-CoV-2-positive patients","volume":"14","author":"Novelli","year":"2020","journal-title":"Hum. Genomics"},{"issue":"5","key":"10.1016\/j.bcp.2026.118007_b0035","doi-asserted-by":"crossref","first-page":"1016","DOI":"10.1016\/j.cell.2020.04.035","article-title":"SARS-CoV-2 receptor ACE2 is an interferon-stimulated gene in human airway epithelial cells and is detected in specific cell subsets across tissues","volume":"181","author":"Ziegler","year":"2020","journal-title":"Cell"},{"issue":"2","key":"10.1016\/j.bcp.2026.118007_b0040","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1038\/s41588-020-00759-x","article-title":"A novel ACE2 isoform is expressed in human respiratory epithelia and is upregulated in response to interferons and RNA respiratory virus infection","volume":"53","author":"Blume","year":"2021","journal-title":"Nat. Genet."},{"issue":"12","key":"10.1016\/j.bcp.2026.118007_b0045","doi-asserted-by":"crossref","first-page":"1283","DOI":"10.1038\/s41588-020-00731-9","article-title":"Interferons and viruses induce a novel truncated ACE2 isoform and not the full-length SARS-CoV-2 receptor","volume":"52","author":"Onabajo","year":"2020","journal-title":"Nat. Genet."},{"issue":"10","key":"10.1016\/j.bcp.2026.118007_b0050","doi-asserted-by":"crossref","first-page":"1143","DOI":"10.1042\/CS20200419","article-title":"Alternative splicing of ACE2 possibly generates variants that may limit the entry of SARS-CoV-2: a potential therapeutic approach using SSOs","volume":"134","author":"Rehman","year":"2020","journal-title":"Clin. Sci."},{"issue":"24","key":"10.1016\/j.bcp.2026.118007_b0055","doi-asserted-by":"crossref","first-page":"2499","DOI":"10.1042\/BCJ20220364","article-title":"Protein targeting by the itaconate family in immunity and inflammation","volume":"479","author":"Day","year":"2022","journal-title":"Biochem. J"},{"issue":"1","key":"10.1016\/j.bcp.2026.118007_b0060","doi-asserted-by":"crossref","first-page":"64","DOI":"10.1016\/j.immuni.2018.11.017","article-title":"The nucleotide sensor ZBP1 and kinase RIPK3 induce the enzyme IRG1 to promote an antiviral metabolic state in neurons","volume":"50","author":"Daniels","year":"2019","journal-title":"Immunity"},{"key":"10.1016\/j.bcp.2026.118007_b0065","doi-asserted-by":"crossref","unstructured":"P. Rib\u00f3-Molina, H.J. Weiss, B. Susma, S. van Nieuwkoop, L. Persoons, Y. Zheng, et al., 4-Octyl itaconate reduces influenza A replication by targeting the nuclear export protein CRM1. Schultz-Cherry S, editor. J Virol. 2023 Oct 12.","DOI":"10.1128\/jvi.01325-23"},{"key":"10.1016\/j.bcp.2026.118007_b0070","doi-asserted-by":"crossref","unstructured":"F.H. Waqas, M. Shehata, W.A.M. Elgaher, A. Lacour, N. Kurmasheva, F. Begnini, et al., NRF2 activators inhibit influenza A virus replication by interfering with nucleo-cytoplasmic export of viral RNPs in an NRF2-independent manner, Yount JS, editor, PLOS Pathog. 2023 Jul 17;19(7):e1011506.","DOI":"10.1371\/journal.ppat.1011506"},{"issue":"2","key":"10.1016\/j.bcp.2026.118007_b0075","doi-asserted-by":"crossref","first-page":"188","DOI":"10.1016\/j.cmet.2020.06.016","article-title":"Omics-driven systems interrogation of metabolic dysregulation in COVID-19 pathogenesis","volume":"32","author":"Song","year":"2020","journal-title":"Cell Metab."},{"issue":"1","key":"10.1016\/j.bcp.2026.118007_b0080","doi-asserted-by":"crossref","first-page":"4938","DOI":"10.1038\/s41467-020-18764-3","article-title":"SARS-CoV2-mediated suppression of NRF2-signaling reveals potent antiviral and anti-inflammatory activity of 4-octyl-itaconate and dimethyl fumarate","volume":"11","author":"Olagnier","year":"2020","journal-title":"Nat. Commun."},{"key":"10.1016\/j.bcp.2026.118007_b0085","article-title":"Janus kinase inhibitors for the treatment of COVID-19","author":"Kramer","year":"2022","journal-title":"Cochrane Database Syst. Rev."},{"key":"10.1016\/j.bcp.2026.118007_b0090","doi-asserted-by":"crossref","unstructured":"V. Selvaraj, A. Finn, A. Lal, M.S. Khan, K. Dapaah-Afriyie, G.P. Carino, Baricitinib in hospitalised patients with COVID-19: a meta-analysis of randomised controlled trials, eClinicalMedicine 2022 Jul;49:101489.","DOI":"10.1016\/j.eclinm.2022.101489"},{"key":"10.1016\/j.bcp.2026.118007_b0095","doi-asserted-by":"crossref","DOI":"10.1016\/j.intimp.2020.106749","article-title":"Baricitinib, a drug with potential effect to prevent SARS-COV-2 from entering target cells and control cytokine storm induced by COVID-19","volume":"86","author":"Zhang","year":"2020","journal-title":"Int. Immunopharmacol."},{"issue":"11","key":"10.1016\/j.bcp.2026.118007_b0100","doi-asserted-by":"crossref","DOI":"10.1016\/j.celrep.2022.110945","article-title":"Baricitinib attenuates the proinflammatory phase of COVID-19 driven by lung-infiltrating monocytes","volume":"39","author":"Dobosh","year":"2022","journal-title":"Cell Rep."},{"issue":"1","key":"10.1016\/j.bcp.2026.118007_b0105","doi-asserted-by":"crossref","DOI":"10.1126\/sciadv.abe4724","article-title":"JAK inhibition reduces SARS-CoV-2 liver infectivity and modulates inflammatory responses to reduce morbidity and mortality","volume":"7","author":"Stebbing","year":"2021","journal-title":"Sci. Adv."},{"issue":"3","key":"10.1016\/j.bcp.2026.118007_b0110","doi-asserted-by":"crossref","first-page":"487","DOI":"10.1016\/j.cmet.2022.02.002","article-title":"Itaconate and itaconate derivatives target JAK1 to suppress alternative activation of macrophages","volume":"34","author":"Runtsch","year":"2022","journal-title":"Cell Metab."},{"issue":"1","key":"10.1016\/j.bcp.2026.118007_b0115","doi-asserted-by":"crossref","first-page":"74","DOI":"10.1159\/000497415","article-title":"TGF-\u03b21 impairs vitamin D-induced and constitutive airway epithelial host defense mechanisms","volume":"12","author":"Schrumpf","year":"2020","journal-title":"J. Innate Immun."},{"issue":"1","key":"10.1016\/j.bcp.2026.118007_b0120","doi-asserted-by":"crossref","first-page":"5838","DOI":"10.1038\/s41467-020-19684-y","article-title":"STAT2 signaling restricts viral dissemination but drives severe pneumonia in SARS-CoV-2 infected hamsters","volume":"11","author":"Boudewijns","year":"2020","journal-title":"Nat. Commun."},{"key":"10.1016\/j.bcp.2026.118007_b0125","doi-asserted-by":"crossref","unstructured":"C. Salgado-Benvindo, M. Thaler, A. Tas, N.S. Ogando, P.J. Bredenbeek, D.K. Ninaber, et al., Suramin inhibits SARS-CoV-2 infection in cell culture by interfering with early steps of the replication cycle, Antimicrob Agents Chemother. 2020 Jul 22;64(8).","DOI":"10.1128\/AAC.00900-20"},{"issue":"20","key":"10.1016\/j.bcp.2026.118007_b0130","doi-asserted-by":"crossref","first-page":"12522","DOI":"10.3390\/ijms232012522","article-title":"Reactive centre loop mutagenesis of SerpinB3 to target TMPRSS2 and furin: inhibition of SARS-CoV-2 cell entry and replication","volume":"23","author":"Singh","year":"2022","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.bcp.2026.118007_b0135","doi-asserted-by":"crossref","unstructured":"S.M. O\u2019Carroll, C.G. Peace, J.E. Toller-Kawahisa, Y. Min, A. Hooftman, S. Charki, et al., Itaconate drives mtRNA-mediated type I interferon production through inhibition of succinate dehydrogenase, Nat. Metab. 2024 Oct 15;.","DOI":"10.1038\/s42255-024-01145-1"},{"key":"10.1016\/j.bcp.2026.118007_b0140","first-page":"10","article-title":"Nrf2 negatively regulates type I interferon responses and increases susceptibility to herpes genital infection in mice","volume":"6","author":"Gunderstofte","year":"2019","journal-title":"Front. Immunol."},{"issue":"7","key":"10.1016\/j.bcp.2026.118007_b0145","doi-asserted-by":"crossref","first-page":"594","DOI":"10.1038\/s42255-020-0210-0","article-title":"Comparative evaluation of itaconate and its derivatives reveals divergent inflammasome and type I interferon regulation in macrophages","volume":"2","author":"Swain","year":"2020","journal-title":"Nat. Metab."},{"issue":"11","key":"10.1016\/j.bcp.2026.118007_b0150","doi-asserted-by":"crossref","first-page":"2895","DOI":"10.1038\/s41401-022-00906-6","article-title":"Transcriptional regulation and small compound targeting of ACE2 in lung epithelial cells","volume":"43","author":"Liang","year":"2022","journal-title":"Acta Pharmacol. Sin."},{"issue":"7699","key":"10.1016\/j.bcp.2026.118007_b0155","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1038\/nature25986","article-title":"Itaconate is an anti-inflammatory metabolite that activates Nrf2 via alkylation of KEAP1","volume":"556","author":"Mills","year":"2018","journal-title":"Nature"},{"issue":"2","key":"10.1016\/j.bcp.2026.118007_b0160","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1007\/s12079-012-0185-z","article-title":"TLR3 activation evokes IL-6 secretion, autocrine regulation of Stat3 signaling and TLR2 expression in human bronchial epithelial cells","volume":"7","author":"Melkamu","year":"2013","journal-title":"J. Cell Commun. Signal."},{"issue":"2","key":"10.1016\/j.bcp.2026.118007_b0165","doi-asserted-by":"crossref","first-page":"141","DOI":"10.3892\/etm.2020.9573","article-title":"4-Octyl itaconate (4-OI) attenuates lipopolysaccharide-induced acute lung injury by suppressing PI3K\/Akt\/NF-\u03baB signaling pathways in mice","volume":"21","author":"Xin","year":"2020","journal-title":"Exp. Ther. Med."},{"issue":"1","key":"10.1016\/j.bcp.2026.118007_b0170","doi-asserted-by":"crossref","first-page":"3513","DOI":"10.1038\/s41467-023-39174-1","article-title":"Dimethyl fumarate and 4-octyl itaconate are anticoagulants that suppress tissue factor in macrophages via inhibition of Type I Interferon","volume":"14","author":"Ryan","year":"2023","journal-title":"Nat. Commun."},{"key":"10.1016\/j.bcp.2026.118007_b0175","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2023.1203756","article-title":"Itaconate family-based host-directed therapeutics for infections","volume":"14","author":"Yuk","year":"2023","journal-title":"Front. Immunol."},{"issue":"5","key":"10.1016\/j.bcp.2026.118007_b0180","first-page":"656","article-title":"Citraconate inhibits ACOD1 catalysis, reduces interferon responses and viral particle release in influenza a infection","volume":"4","author":"Michelucci","year":"2022","journal-title":"Nat Metab."}],"container-title":["Biochemical Pharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0006295226003400?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0006295226003400?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,10,25]],"date-time":"2026-10-25T00:31:33Z","timestamp":1792888293000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0006295226003400"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,8]]},"references-count":36,"alternative-id":["S0006295226003400"],"URL":"https:\/\/doi.org\/10.1016\/j.bcp.2026.118007","relation":{},"ISSN":["0006-2952"],"issn-type":[{"value":"0006-2952","type":"print"}],"subject":[],"published":{"date-parts":[[2026,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"4-Octyl itaconate blocks STAT3-induced ACE2 expression to reduce uptake of SARS-CoV-2","name":"articletitle","label":"Article Title"},{"value":"Biochemical Pharmacology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.bcp.2026.118007","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 The Authors. Published by Elsevier Inc.","name":"copyright","label":"Copyright"}],"article-number":"118007"}}